生醫光電市場規模、佔有率、按技術、應用、最終用途和地區分類的成長分析 - 2025-2032 年產業預測

預計到 2023 年生醫光電市場規模將達到 652 億美元，從 2024 年的 726.3 億美元成長到 2032 年的 1,722.7 億美元，預測期內（2025-2032 年）的複合年成長率為 11.4%。

由於對非侵入性診斷技術的需求不斷增加，全球生醫光電市場正經歷顯著成長。傳統方法通常涉及侵入性手術，使患者面臨風險和不適。生醫光電利用基於光的技術來分析活組織，無需手術干預即可提供準確、即時的影像解決方案。眼科中的光學相干斷層掃描 (OCT) 等技術有助於早期發現眼科疾病，而螢光影像則可改善癌症診斷。隨著醫療保健系統優先考慮安全性和效率，生醫光電的採用將會加速。光電和分子成像技術的進步將進一步提高影像解析度，從而能夠檢測到疾病的早期跡象。量子點和等離子體奈米粒子的創新正在徹底改變生物感測並提高疾病生物標記的特異性。這些技術進步正在拓寬生醫光電在診斷和個人化醫療的應用範圍，推動市場擴張。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

生醫光電市場規模（依技術及複合年成長率） (2025-2032)

• 市場概覽
• 體外
• 體內

生醫光電市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概覽
• 透視成像
• 顯微鏡
• 內部影像
• 光譜分子
• 分析感測
• 光療法
• 表面成像
• 生物感測器

生醫光電市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概覽
• 測試和組件
• 醫療
• 醫療診斷
• 非醫療用途

生醫光電市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Carl Zeiss AG（Germany）
• Olympus Corporation（Japan）
• Thorlabs, Inc.（USA）
• Hamamatsu Photonics KK（Japan）
• Nikon Corporation（Japan）
• Coherent, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Bruker Corporation（USA）
• ZEISS Group（Germany）
• Horiba, Ltd.（Japan）
• Photonics Industries International, Inc.（USA）
• MKS Instruments, Inc.（USA）
• Edmund Optics, Inc.（USA）
• Jenoptik AG（Germany）

結論和建議

Biophotonics Market size was valued at USD 65.2 billion in 2023 and is poised to grow from USD 72.63 billion in 2024 to USD 172.27 billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The global biophotonics market is experiencing significant growth driven by the increasing demand for non-invasive diagnostic technologies. Traditional methods often involve invasive procedures, posing risks and discomfort for patients. Biophotonics utilizes light-based techniques to analyze biological tissues, offering accurate, real-time imaging solutions without surgical intervention. Technologies like optical coherence tomography (OCT) in ophthalmology facilitate early detection of eye diseases, while fluorescence imaging enhances cancer diagnosis. As healthcare systems prioritize safety and efficiency, biophotonics adoption accelerates. Advancements in nanophotonics and molecular imaging further enhance image resolution and enable detection of early disease signs. Innovations with quantum dots and plasmonic nanoparticles are revolutionizing biosensing, improving the specificity of disease biomarkers. This technological evolution is broadening the applications of biophotonics in diagnostics and personalized medicine, driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biophotonics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biophotonics Market Segments Analysis

Global Biophotonics Market is segmented by Technology, Application, End Use and region. Based on Technology, the market is segmented into In-Vitro and In-Vivo. Based on Application, the market is segmented into See-Through imaging, Microscopy, Inside Imaging, Spectro Molecular, Analytics Sensing, Light Therapy, Surface Imaging and Biosensors. Based on End Use, the market is segmented into Tests and Components, Medical Therapeutics, Medical Diagnostics and Non-medical Application. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biophotonics Market

The global biophotonics market is primarily driven by the rising demand for non-invasive medical techniques. This innovative field facilitates real-time, high-resolution imaging, which is essential for early detection of diseases and the advancement of precision medicine. As instances of cancer, neurological conditions, and cardiovascular diseases continue to rise, healthcare professionals are increasingly turning to biophotonic technologies. These solutions not only ensure safer diagnostic procedures but also enhance the effectiveness of treatment options, making them a preferred choice in modern healthcare. Consequently, the growing inclination towards biophotonics is significantly propelling the market forward.

Restraints in the Biophotonics Market

The Biophotonics market faces significant constraints primarily due to the high costs associated with its devices and infrastructure, which serve as major hindrances to market growth. The advanced nature of optical imaging systems, laser-based diagnostics, and biosensors requires considerable financial investment, making these technologies less accessible, particularly in developing regions. Moreover, the necessity for skilled professionals to effectively operate these sophisticated technologies exacerbates the overall implementation costs. As a result, these factors collectively impede the widespread adoption and expansion of biophotonics solutions, limiting their potential impact in various sectors, particularly in areas that could greatly benefit from such advancements.

Market Trends of the Biophotonics Market

The biophotonics market is witnessing a significant shift towards personalized healthcare solutions, exemplified by innovative startups like Luma Biophotonics. Established in 2021, Luma is at the forefront of this trend, delivering compact, cost-effective home diagnostic devices that empower individuals to monitor their health conveniently. Utilizing advanced Photonic Integrated Circuits (PICs), their flagship analyzer facilitates multianalyte testing, enabling timely health insights while reducing reliance on clinical visits. The development of polymeric PICs, which offer comparable performance to traditional silicon variants at lower costs, exemplifies a crucial advancement. This democratization of advanced diagnostics not only enhances early disease detection but also promotes tailored treatment approaches, driving substantial growth in the biophotonics market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Biophotonics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• In-Vitro
• In-Vivo

Global Biophotonics Market Size by Application & CAGR (2025-2032)

• Market Overview
• See-Through imaging
• Microscopy
• Inside Imaging
• Spectro Molecular
• Analytics Sensing
• Light Therapy
• Surface Imaging
• Biosensors

Global Biophotonics Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Tests and Components
• Medical Therapeutics
• Medical Diagnostics
• Non-medical Application

Global Biophotonics Market Size & CAGR (2025-2032)

• North America (Technology, Application, End Use)
  • US
  • Canada
• Europe (Technology, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Carl Zeiss AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thorlabs, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikon Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coherent, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZEISS Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horiba, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Photonics Industries International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MKS Instruments, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edmund Optics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jenoptik AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations